BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26924320)

  • 1. Bioreductive fluorescent imaging agents: applications to tumour hypoxia.
    Elmes RB
    Chem Commun (Camb); 2016 Jul; 52(58):8935-56. PubMed ID: 26924320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs.
    Shen X; Laber CH; Sarkar U; Galazzi F; Johnson KM; Mahieu NG; Hillebrand R; Fuchs-Knotts T; Barnes CL; Baker GA; Gates KS
    J Org Chem; 2018 Mar; 83(6):3126-3131. PubMed ID: 29461834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A highly sensitive long-wavelength fluorescence probe for nitroreductase and hypoxia: selective detection and quantification.
    Guo T; Cui L; Shen J; Zhu W; Xu Y; Qian X
    Chem Commun (Camb); 2013 Nov; 49(92):10820-2. PubMed ID: 24121427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-selective, enzymatic conversion of 6-nitroquinoline into a fluorescent helicene: pyrido[3,2-f]quinolino[6,5-c]cinnoline 3-oxide.
    Rajapakse A; Gates KS
    J Org Chem; 2012 Apr; 77(7):3531-7. PubMed ID: 22417220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naphthalimides in fluorescent imaging of tumor hypoxia - An up-to-date review.
    Kumari R; Sunil D; Ningthoujam RS
    Bioorg Chem; 2019 Jul; 88():102979. PubMed ID: 31100616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FSL-61 is a 6-nitroquinolone fluorogenic probe for one-electron reductases in hypoxic cells.
    Su J; Guise CP; Wilson WR
    Biochem J; 2013 May; 452(1):79-86. PubMed ID: 23480813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recognition Moieties of Small Molecular Fluorescent Probes for Bioimaging of Enzymes.
    Wu X; Shi W; Li X; Ma H
    Acc Chem Res; 2019 Jul; 52(7):1892-1904. PubMed ID: 31243972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel fluorescent markers for hypoxic cells of naphthalimides with two heterocyclic side chains for bioreductive binding.
    Liu Y; Xu Y; Qian X; Liu J; Shen L; Li J; Zhang Y
    Bioorg Med Chem; 2006 May; 14(9):2935-41. PubMed ID: 16403640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Nitroimidazole-tricarbocyanine conjugate as a near-infrared fluorescent probe for in vivo imaging of tumor hypoxia.
    Okuda K; Okabe Y; Kadonosono T; Ueno T; Youssif BG; Kizaka-Kondoh S; Nagasawa H
    Bioconjug Chem; 2012 Mar; 23(3):324-9. PubMed ID: 22335430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design strategy of optical probes for tumor hypoxia imaging.
    Xue F; Chen J; Chen H
    Sci China Life Sci; 2020 Dec; 63(12):1786-1797. PubMed ID: 32146696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photophysical Tuning of N-Oxide-Based Probes Enables Ratiometric Photoacoustic Imaging of Tumor Hypoxia.
    Knox HJ; Kim TW; Zhu Z; Chan J
    ACS Chem Biol; 2018 Jul; 13(7):1838-1843. PubMed ID: 29521492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smart Fluorescent Probe Strategy for Precision Targeting Hypoxic Tumor.
    Wang Y; Chen L
    J Med Chem; 2021 Mar; 64(6):2967-2970. PubMed ID: 33728917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a bioreductively-activated fluorescent pH probe for tumor hypoxia imaging.
    Nakata E; Yukimachi Y; Kariyazono H; Im S; Abe C; Uto Y; Maezawa H; Hashimoto T; Okamoto Y; Hori H
    Bioorg Med Chem; 2009 Oct; 17(19):6952-8. PubMed ID: 19736018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of one-electron reductases that activate both the hypoxia prodrug SN30000 and diagnostic probe EF5.
    Wang J; Guise CP; Dachs GU; Phung Y; Hsu AH; Lambie NK; Patterson AV; Wilson WR
    Biochem Pharmacol; 2014 Oct; 91(4):436-46. PubMed ID: 25130546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversible off-on fluorescence probe for hypoxia and imaging of hypoxia-normoxia cycles in live cells.
    Takahashi S; Piao W; Matsumura Y; Komatsu T; Ueno T; Terai T; Kamachi T; Kohno M; Nagano T; Hanaoka K
    J Am Chem Soc; 2012 Dec; 134(48):19588-91. PubMed ID: 23157219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescent Mechanism-Based Probe for Aerobic Flavin-Dependent Enzyme Activity.
    McCulloch IP; La Clair JJ; Jaremko MJ; Burkart MD
    Chembiochem; 2016 Sep; 17(17):1598-601. PubMed ID: 27271974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Tetraphenylethylene-Derived Fluorescent Probe for Nitroreductase Detection and Hypoxic-Tumor-Cell Imaging.
    You X; Li L; Li X; Ma H; Zhang G; Zhang D
    Chem Asian J; 2016 Oct; 11(20):2918-2923. PubMed ID: 27534906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs.
    Phillips RM
    Cancer Chemother Pharmacol; 2016 Mar; 77(3):441-57. PubMed ID: 26811177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new prodrug-derived ratiometric fluorescent probe for hypoxia: high selectivity of nitroreductase and imaging in tumor cell.
    Cui L; Zhong Y; Zhu W; Xu Y; Du Q; Wang X; Qian X; Xiao Y
    Org Lett; 2011 Mar; 13(5):928-31. PubMed ID: 21268631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel aliphatic N-oxide of naphthalimides as fluorescent markers for hypoxic cells in solid tumor.
    Yin H; Zhu W; Xu Y; Dai M; Qian X; Li Y; Liu J
    Eur J Med Chem; 2011 Jul; 46(7):3030-7. PubMed ID: 21550698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.